Insights On Pharmaceutical Production

  1. Robust Development Of Downstream Process Technologies For AAV 4/17/2024

    The focus of this study was to optimize the three primary downstream processing steps for AAV particle purification utilizing a design of experiments (DoE) methodology and screening devices.

  2. Mitigating Powder Flow And Static Issues Using SYLOID® Mesoporous Silica 10/7/2025

    See how incorporating small amounts of mesoporous silica during micronization can significantly enhance powder flow, thereby making subsequent blending and formulation more efficient and consistent.

  3. End-To-End Single-Use Downstream Solution For Bio-Manufacturing 9/4/2024

    Watch to learn about the advantages of applying single-use platform technologies, how to debottleneck process intensification, and much more.

  4. Mycoplasma Testing In Monoclonal Antibody Production 6/17/2024

    Prevent costly disruptions in your bioproduction process. Discover how a PCR-based method can quickly detect the presence of mycoplasmas in raw materials, cell banks, and in-process and lot-release samples.

  5. Viruses And Viral Vectors, Are They Different? 10/23/2024

    Learn how effective disinfection solutions can ensure safety in pharmaceutical manufacturing by managing viral contaminants and enhancing patient protection.

  6. Collaborative Bioprocessing: Next-Gen mAb Downstream Manufacturing 9/23/2024

    Explore the bioprocessing template, operational paradigm, and the complexities of qualifying an advanced, highly automated bioprocessing train designed for the production of mAbs and other biologics.

  7. The Status Quo Of Oligonucleotides Is Not The Future 12/2/2024

    The oligonucleotide field is booming, but manufacturing challenges loom. Experts discuss optimizing production for these promising therapies with flexible, sustainable, and high-yield approaches.

  8. Dry Powder Media Manufacturing Grand Island Expansion 11/5/2025

    Take a video tour of our newly expanded dry powder media manufacturing facility in Grand Island, New York. The expansion has added more than 45,000 square feet of Animal Origin Free (AOF) manufacturing space to help meet increasing global demand.

  9. A New Way To Perform mAb Capture 2/21/2024

    Combining high-productivity chromatography methods and SU affinity membranes delivers a viable alternative to the current packed bed Protein A capture techniques for intensified purification of mAbs.

  10. A New Framework For Identifying Nitrosamine Risks And Derisking Products 6/18/2024

    Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.